Journal Top Ten
April 8, 2002
photo-6
photo-7 Related Drug: Baycol/Zocor
Article: "FDA Adverse Event Reports on Statin-Associated Rhabdomyolysis"
Summary: A review and profile of the number of cases of statin-associated rhabdomyolysis reported to the FDA between November 1997 and March 2000. The review revealed that of 871 reports of statin-associated cases of rhabdomyolysis, 35.8 percent were assoicated with simvastatin (Zocor), and 31.9 percent with cerivastatin (Baycol). The results led the researchers to conclude that both are implicated in a relatively higher number of adverse reports than the remaining statins; however, they urged caution in interpreting the data because of the various limitations of a …
UPCOMING CONFERENCES
HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates
May 29, 2024 - Salt Lake City, UT
The Grand America Hotel
HarrisMartin's Mass Tort Settlements Conference - Sponsored by Milestone
June 27, 2024 - Buffalo, NY
The Richardson Hotel Buffalo